First Clinical Use Of Carmell Therapeutics' Plasma-Based Biomaterial Reduces Infections, Speeds Healing Of Bone Fractures

CAPE TOWN, South Africa--(BUSINESS WIRE)--South African Orthopaedic Association Congress, Cape Town – Data presented this week from a recently completed clinical trial with the REPAIR™ Bone Putty show the blood plasma-based Putty reduced infections, sped bone healing, and promoted more rapid wound closure of open tibia fractures. Dr. David North, an orthopaedic surgeon associated with the University of Cape Town, presented the findings.

The REPAIR Putty incorporates a novel material made from blood plasma containing a concentration of natural healing factors that bathe the injured tissue as the material degrades. This first study was designed to assess the safety and performance of the Putty in augmenting the healing of fractures.

Hey, check out all the research scientist jobs. Post your resume today!